Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; ÎKG; α-ketoglutarate; AML; acute myeloid leukemia; BCAT1; branched-chain amino acid transporter 1; BRD4; bromodomain-containing protein 4; D-2HG; D-2-hydroxyglutarate or R-2-hydroxyglutarate; D-2HGA; D-2-hydroxyglutarate aciduria; D2HGDH; D-2-hydroxyglu
مقالات ISI لوسمی حاد میلوئیدی یا به اختصار AML (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; HCT; hematopoietic cell transplantation; allo-HCT; allogeneic-hematopoietic cell transplantation; ARDS; acute respiratory distress syndrome; CMV; cytomegalovirus; PCR; polymerase chain reaction; BAL; bronchoalveolar lavage; OIs; opportunistic infections;
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; CVC; Central venous catheters; CRT; Central venous catheters related thrombosis; AML; acute myeloid leukemia; LMWH; low molecular weight heparin; PLT; platelet; PE; pulmonary embolism; DVT; deep vein thrombosis; VTE; venous thromboembolism; SVC; non-tunne
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Etoposide; Cyclophosphamide; Acute myeloid leukemia; Complete remission;
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Extramedullary disease; Relapse; Allogeneic transplantation;
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Costs; Acute myeloid leukemia; Induction treatment; Consolidation treatment; Follow-up; Cost components;
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Invasive fungal infections; Acute myeloid leukemia; Epidemiology; Risk factors; Survival;
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Allogeneic transplantation; Myelodysplastic syndromes; Performance status; Prognosis; Therapy;
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Cytokines; Chemokines; Interleukins; Tumor necrosis factor; Interferon; Cancer-related fatigue; Quality of life;
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; High-throughput RNA sequencing; Chronic myeloid leukemia; Acute myeloid leukemia;
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; CoCl2; cobalt chloride; AML; acute myeloid leukemia; HIF-1 α; hypoxia-inducible factor-1 α; CQ; chloroquine; LAMP1 and 2; lysosome-associated membrane proteins 1 and 2; APL; acute promyelocytic leukemia; ATRA; all-trans retinoic acid; ATO; arsenic triox
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Leukemia; Acute myeloid leukemia; Chronic myeloid leukemia; Cigarette smoking; Smoking cessation;
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; DNA methylation; Targeted bisulfite sequencing; Next-generation sequencing; ACBS-seq; array capture bisulfite sequencing; AML; acute myeloid leukemia; BSPP; bisulfite padlock probes; CGI; CpG island; COBRA; combined bisulfite and restriction analysis; DMH
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; AML; acute myeloid leukemia; CAM-DR; cell adhesion-mediated drug resistance; CCP; charge-conversion polymer; CLL; chronic lymphocytic leukemia; CNS; central nervous system; CSC; cancer stem cell; EGFR; epidermal growth factor receptor; EPR; enhanced perme
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; AAc; Acrylic acid; AML; Acute myeloid leukemia; BCP; Block copolymer; BK; Bradykinin; CD; Cyclodextrin; Chol; Cholesterol; CSC; Cancer stem cells; CTAB; Cetyltrimethylammonium bromide; DDS; Drug delivery system; Dex; Dexamethasone; DLL4; Delta-like 4 liga
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Sesquiterpene lactone; Apoptosis
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Telomere length; Clinical outcomes; Somatic mutations
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Basophilia; Basophilic blasts; Megakaryoblasts
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Clinical trial; Cytarabine; Lenalidomide; Phase I; Relapse/refractory AML
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Second allogeneic stem cell transplantation; Relapse; Acute myeloid leukemia; Myeloid malignancies
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Low-intensity treatment regimen; Infection; Antibiotic prophylaxis
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Therapy; Blood transfusion; Cost-effectiveness; PrognosisLeucémie aiguë myéloïde; Traitement; Transfusion sanguine; Coût-efficacité; Pronostic
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; AAV; adeno-associated viruses; Ad6; adenovirus serotype 6; ABCB5Â +; ATP-binding cassette sub-family B member 5; ALDH; aldehyde dehydrogenase; AML; acute myeloid leukemia; APCs; antigen presenting cells; B7.1; (CD80) cluster of differentiation 80; BCG; Ba
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Relapsed; Refractory; Pravastatin; Idarubicin; Cytarabine;
H2AFY is a novel fusion partner of MECOM in acute myeloid leukemia
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; MECOM; H2AFY; Acute myeloid leukemia;
Predicted indirectly recognizable HLA epitopes are not associated with clinical outcomes after haploidentical hematopoietic stem cell transplantation
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; HLA allele; PIRCHE; Haploidentical; Outcome; haplo-SCT; Haploidentical stem cell transplantation; HLA; human leukocyte antigen; PIRCHE; Predicted Indirectly ReCognizable HLA Epitopes; GVHD; chronic graft-versus-host disease; AML; acute myeloid leukemia; A
High frequency of dicentric chromosomes detected by multi-centromeric FISH in patients with acute myeloid leukemia and complex karyotype
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Complex karyotype; Dicentric chromosomes; Acute myeloid leukemia; Fluorescence in situ hybridization; Centromere;
Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemia
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; FLT3-ITD; Induction chemotherapy; Anthracycline;
Allogeneic Transplantation for Acute Myelogenous Leukemia in CR1
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute Myeloid Leukemia; Population-based; Allogenic stem-cell transplantation; Comparative effectiveness; Survival; Chemotherapy;
Pulmonary Langerhans cell histiocytosis, acute myeloid leukemia, and myelofibrosis in a large family and review of the literature
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Langerhans cell histiocytosis; Acute myeloid leukemia; Idiopathic myelofibrosis; Familial; Genetic;
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Allogeneic hematopoietic stem cell transplantation; Acute myeloid leukemia; Elderly; Haploidentical donor; Unrelated donor;
In-vitro blockade of the CD4 receptor co-signal in antigen-specific T-cell stimulation cultures induces the outgrowth of potent CD4 independent T-cell effectors
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; AML; acute myeloid leukemia; ELISpot; enzyme-linked immunosorbent spot; LCL; Epstein-Barr virus-transformed B-lymphoblastoid cell lines; HLA; human leukocyte antigen; IFN; interferon; IL; interleukin; mAb; monoclonal antibody; DC; monocyte-derived dendrit
Dihydromyricetin sensitizes human acute myeloid leukemia cells to retinoic acid-induced myeloid differentiation by activating STAT1
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Myeloid differentiation; Acute myeloid leukemia; Dihydromyricetin; ATRA; STAT1;
PML nuclear bodies, membrane-less domains acting as ROS sensors?
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; AKT; AKT serine/threonine kinase; AMPK; AMP activated protein kinase; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; FOXO1; forkhead box O1; FAO; fatty acid oxidation; HIF1A; hypoxia inducible factor 1 alpha subunit; KEAP1; Kelch-like ery
SPG6 supports development of acute myeloid leukemia by regulating BMPR2-Smad-Bcl-2/Bcl-xl signaling
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; SPG6; Acute myeloid leukemia; BMPR2; Apoptosis;
Rapid Fire: Acute Blast Crisis/Hyperviscosity Syndrome
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Blast; Leukostasis; Leukapheresis; Petechiae; Hyperviscosity; Chronic myeloid leukemia; Acute myeloid leukemia; Hydroxyurea;
FLT3 receptor/CD135 expression by flow cytometry in acute myeloid leukemia: Relation to FLT3 gene mutations and mRNA transcripts
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; AML; acute myeloid leukemia; ANOVA; analysis of variance; BM; bone marrow; CT; cycle threshold; DNA; deoxyribonucleic acid; FAB; French-American-British; FISH; fluorescence in situ hybridization; FLK2; fetal liver tyrosine kinase 2; FLT3; FMS-like tyrosin
Anti-c-Mpl antibodies in immune thrombocytopenia suppress thrombopoiesis and decrease response to rhTPO
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; (anti-c-Mpl) antibodies; anti-TPO receptor; anti-c-Mpl+; anti-c-Mpl-antibody-positive; anti-c-Mplâ; anti-c-Mpl-antibody-negative; ITP; immune thrombocytopenia; IVIG; intravenous immunoglobulin; TPO; thrombopoietin; TPO-RAs; TPO receptor agonists; rhTPO;
An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Gemtuzumab ozogamicin; mTOR inhibitor; Lysosomal function; Cell cycle;
Prophylactic administration of voriconazole with two different doses for invasive fungal infection in children and adolescents with acute myeloid leukemia
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; acute myeloid leukemia; concentration; invasive fungal infection; prophylaxis; voriconazole;
High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; AML; acute myeloid leukemia; BM; bone marrow; CR; complete remission; FAB; French-American-British; HRMA; high-resolution melting analysis; RQ-PCR; real-time quantitative PCR; ROC; receiver operating characteristic; AUC; area under the ROC curve; OS; over
A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Rigosertib; Myelodysplastic syndrome; Acute myeloid leukemia; Refractory; Cell cycle; Ras inhibitor;
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Favorable risk; Core binding factor; Molecular diagnostics;
Prognostic significance of SOX2, SOX3, SOX11, SOX14 and SOX18 gene expression in adult de novo acute myeloid leukemia
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; SOX genes; Prognosis;
CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; ANC; Absolute neutrophil count; AML; Acute myeloid leukemia; BL; Baseline; BM; Bone marrow; CI; Confidence intervals; CMML; Chronic myelomonocytic leukemia; CR; Complete remission; ECOG; Eastern Cooperative Oncology Group; HI; Hematologic improvement; HI-
Interaction between the immune system and acute myeloid leukemia: A model incorporating promotion of regulatory T cell expansion by leukemic cells
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Computational model; Regulatory T cells; Bistability; Immunotherapy;
Differential expression profiles of miRNAs and correlation with clinical outcomes in acute myeloid leukemia
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; microRNA expression; acute myeloid leukemia; clinical outcomes; cancers;
CXCL8 is associated with the recurrence of patients with acute myeloid leukemia and cell proliferation in leukemia cell lines
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; CXCL8; Cytokines; Gene expression profiling; Proliferation;
Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; AML; acute myeloid leukemia; GO; gemtuzumab ozogamacin; PBD; pyrrolobenzodiazepine; HuM196; humanized murine 196; CARs; chimeric antigen receptors; LAA; leukemia associated antigens; TCRT; cell receptor; NKG2D; natural killer group 2 D; MHC; major histoco
Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study
Keywords: لوسمی حاد میلوئیدی یا به اختصار AML; Acute myeloid leukemia; Prognosis; Risk stratification; European LeukemiaNet; Genetics;